IL17A and asthma: We found that treatment with DNase I and Cl-amidine reduced neutrophil and Th17 counts and IL-17A production in lungs of OVA+LPS mice and protected the mice on the development of asthma, suggesting that NETs could mediate the Th17-mediated neutrophilic airway inflammation in the OVA+LPS mice models tested here.